How does Cryopen selectively destroy angiofibroma tissue without affecting surrounding dermis?

Cryopen works by delivering liquid nitrogen at ultra-low temperatures (-40°C) directly to the angiofibroma. This rapid freezing causes intracellular ice crystals to form inside the fibroblasts and vascular cells of the lesion, leading to irreversible cell damage and apoptosis. Surrounding dermal structures, including collagen, melanocytes, and healthy capillaries, remain largely unaffected because the Cryopen’s nozzle delivers a highly focused, controlled spray. This pinpoint accuracy ensures that only the lesion is destroyed, minimizing the risk of scarring, textural changes, or pigmentary alterations in the surrounding skin.

Why are angiofibromas vascular and fibrous in nature, and how does this affect treatment choice?

Angiofibromas are histologically composed of dense collagen bundles intertwined with proliferating capillaries. The vascular component makes them red or reddish-brown, while the fibrous matrix gives them firmness. This dual nature influences treatment selection: laser therapy is highly effective for targeting the blood vessels, causing them to coagulate without affecting surrounding tissue, whereas Cryopen or radiofrequency ablation is better at disrupting the dense fibrous tissue. Understanding the lesion’s histology allows specialists to choose a method that maximizes efficacy while minimizing downtime and cosmetic complications.

How does lesion size and depth influence the method of removal?

The size and depth of an angiofibroma are critical in deciding the treatment approach. Small, superficial papules often respond fully to a single Cryopen session or laser pulse because the cryogenic or photothermal energy can penetrate the entire lesion. Larger or deeper lesions, particularly those with a dense fibrous core, may require radiofrequency ablation or surgical excision to ensure complete removal. Incomplete treatment can leave residual fibrovascular tissue, increasing the risk of recurrence. Therefore, precise assessment of lesion morphology before treatment is essential for optimal outcomes.

What determines whether an angiofibroma flattens naturally after Cryopen versus requiring a second session?

After Cryopen treatment, some angiofibromas resolve completely after one application, while others regress gradually over several weeks. The difference depends on cellular density, vascularity, and lesion chronicity. Lesions with a dense fibrous matrix or thicker vascular networks may retain some viable cells after the first freeze, requiring a follow-up session to ensure full regression. Additionally, individual variations in skin regenerative capacity, immune response, and vascular repair influence how quickly and completely the lesion flattens.

Why does laser therapy reduce post-inflammatory hyperpigmentation risk in vascular angiofibromas?

Selective wavelength lasers target hemoglobin in the lesion’s capillaries while sparing melanocytes in surrounding skin. This selective photothermolysis causes vascular coagulation within the lesion without triggering significant inflammatory pathways that lead to post-inflammatory hyperpigmentation (PIH). Moreover, by avoiding excessive thermal damage to adjacent dermis, laser therapy minimizes scarring, pigment irregularities, and unwanted textural changes, making it suitable for facial angiofibromas in patients with various skin tones.

How does radiofrequency ablation achieve precision on clustered lesions?

Radiofrequency ablation uses high-frequency electrical currents delivered via microelectrodes to generate controlled heat within the lesion. Specialists can modulate the energy output, duration, and penetration depth for each individual lesion, allowing multiple clustered angiofibromas to be treated in one session without merging the treatment zones. This precise control ensures complete ablation of fibrovascular tissue while preserving healthy skin between lesions. Post-procedure healing is rapid, with minimal crusting or erythema.

What are the cellular effects of cryotherapy on the fibrous component of angiofibromas?

Cryotherapy induces apoptosis and necrosis in fibroblasts and endothelial cells by disrupting cellular membranes through ice crystal formation. The fibrous collagen network inside the lesion may partially denature, causing structural collapse of the angiofibroma. Importantly, collagen outside the lesion remains intact, preserving skin firmness and elasticity. This selective cellular destruction is why Cryopen is considered both effective and safe for cosmetic areas like the nose, cheeks, and chin.

Are there specific anatomical locations where angiofibromas are more resistant to treatment?

Yes. Areas like the nasolabial folds, perinasal skin, and chin often have thicker dermis and a richer vascular supply, which can make lesions more resilient to single-session treatment. Multiple Cryopen pulses, combined laser therapy, or staged RF ablation may be necessary to fully eradicate these resistant lesions. Specialist evaluation is critical to map lesion depth, vascularity, and proximity to sensitive structures to ensure complete removal with minimal complications.

How is treatment tailored for angiofibromas in patients with Tuberous Sclerosis Complex (TSC)?

Patients with TSC often present with multiple, dense, and recurrent angiofibromas. Treatment must be incremental to avoid cumulative tissue trauma and pigmentary issues. Cryopen is often used first for smaller lesions, followed by laser therapy for highly vascular lesions and RF ablation for larger fibrous papules. Regular monitoring and staged sessions are critical, as untreated lesions can impact appearance, psychosocial well-being, and, in rare cases, cause discomfort.

What histological features determine post-treatment healing time?

Healing time is influenced by vascular density, fibrous thickness, and lesion chronicity. High vascularity often leads to mild erythema or temporary swelling post-treatment, whereas dense fibrous cores may form micro-crusts that slough off gradually over 7–14 days. Superficial lesions with minimal vascular content can heal more quickly, sometimes within 5–7 days. Cellular turnover, skin type, and individual immune response also affect recovery and pigmentation outcomes.

How do you minimize recurrence risk after Cryopen or RF ablation?

Recurrence is minimized by ensuring complete destruction of both fibroblastic and vascular components of the lesion. Specialists use precise mapping, controlled energy delivery, and sometimes staged follow-up sessions to target any residual cells. Post-treatment care, including sun protection and avoiding trauma to treated areas, supports optimal skin regeneration and reduces the chance of regrowth.

Why might surgical excision still be preferred despite effective non-invasive methods?

Surgical excision allows complete removal of large, symptomatic, or ulcerated lesions, including deep fibrous roots, which non-invasive methods may not fully eradicate. While Cryopen, laser, and RF treatments are effective for many angiofibromas, surgery provides immediate resolution, especially when lesions interfere with nasal function, are highly fibrotic, or have failed previous non-invasive treatments. Skilled excision also allows precise closure for optimal cosmetic outcomes, particularly in prominent facial areas.

Angiofibroma Treatment with CryoPen Pinner

Information, Assessment & Cryotherapy for Previously Diagnosed Benign Angiofibromas

Angiofibromas are benign skin growths made up of fibrous tissue and blood vessels. They can appear as small, firm, flesh-coloured, pink or reddish bumps on the skin.

Lipo 360 provides CryoPen treatment for suitable angiofibromas that have previously been appropriately assessed and identified as benign.

Treatment is subject to consultation and individual suitability assessment.

Because different skin lesions can sometimes look similar, Lipo 360 does not diagnose angiofibromas. An appropriate healthcare professional should assess new, changing, unusual, or undiagnosed lesions before considering cosmetic treatment.

What Is an Angiofibroma?

A cutaneous angiofibroma is a benign skin growth containing fibrous tissue and blood vessels.

Different forms of angiofibroma can occur. A solitary fibrous papule, for example, commonly appears on the face or nose in adults.

Angiofibromas may appear as small, firm, dome-shaped bumps and can be flesh-coloured, pink or reddish in appearance.

Some people develop a single lesion, while multiple angiofibromas can occur in association with certain medical or genetic conditions.

Angiofibromas are benign, but other skin lesions can sometimes look similar.

For this reason, cosmetic treatment should not replace appropriate medical assessment and diagnosis.

CryoPen Treatment for Angiofibromas

CryoPen is a handheld cryotherapy device that delivers a controlled application of nitrous oxide to a localised treatment area.

For a suitable, previously diagnosed benign angiofibroma, your practitioner can discuss whether CryoPen may be an appropriate cosmetic treatment option.

Following treatment, the area goes through a healing process and may temporarily become red, tender, swollen, darker or crusted. Blistering or changes in pigmentation can also occur.

Individual responses, healing times and cosmetic outcomes vary.

CryoPen treatment does not guarantee complete removal, and some lesions may require further treatment.

What Happens at My Consultation?

Your appointment begins with a consultation and assessment of the area you would like treated.

Your practitioner will discuss:

the lesion you would like treated
whether it has previously been appropriately assessed and diagnosed
your relevant medical history
your skin type and pigmentation
the location and characteristics of the lesion
whether CryoPen treatment may be suitable
possible risks and side effects
what to expect following treatment
appropriate aftercare

If there is uncertainty about the lesion or its appearance gives the practitioner reason for concern, cosmetic treatment will not proceed.

You may instead be advised to seek assessment from your GP, dermatologist or another appropriate healthcare professional.

If treatment is suitable, your practitioner will explain the procedure before you decide whether to proceed.

What Might My Skin Look Like After CryoPen Treatment?

Skin responses to cryotherapy vary between individuals.

Following treatment, you may experience temporary:

redness
tenderness or discomfort
swelling
blistering
darkening of the treatment area
crusting or scabbing
changes in pigmentation

Allow the area to heal naturally. Avoid picking at any crust or scab that develops.

Your practitioner will provide appropriate aftercare guidance following treatment.

Healing time varies depending on the individual, treatment area and characteristics of the lesion.

How Many Treatments Might I Need?

There is no fixed number of treatments that applies to everyone.

Some lesions may be treated during one appointment, while others may require further treatment after the area has completely healed.

This can depend on factors including:

the size of the lesion
its location
the characteristics of the lesion
your skin
your individual response to cryotherapy
how the area heals

We cannot guarantee that a particular number of sessions will produce a specific cosmetic result.

Your practitioner can reassess the area after it has healed and discuss whether further treatment may be appropriate.

Can Angiofibromas Return?

Treatment does not guarantee that an angiofibroma will not recur.

Recurrence can vary depending on the angiofibroma type and individual circumstances.

If you notice a new lesion or a previously treated area changes unexpectedly, seek appropriate advice rather than assuming that it is an angiofibroma.

Who May Be Suitable for CryoPen Treatment?

CryoPen may be considered for adults with suitable angiofibromas that have previously been appropriately assessed and identified as benign.

Suitability is assessed individually.

Treatment may not be appropriate for everyone. Your practitioner will consider factors including:

the diagnosis and appearance of the lesion
its location
your medical history
medication
skin condition
pigmentation
previous reactions to treatment
healing history

Your practitioner will discuss your individual suitability before treatment.

When Should I Have a Skin Lesion Checked?

Do not assume that a new or unusual skin growth is an angiofibroma.

Seek appropriate medical advice if a lesion is:

new or unexplained
changing in size, shape or colour
bleeding without an obvious reason
ulcerated or repeatedly crusting
persistently painful, itchy or inflamed
noticeably different from other lesions on your skin
causing you concern for any other reason

Lipo 360 does not use cosmetic CryoPen treatment to diagnose or investigate suspicious or undiagnosed skin lesions.

If your practitioner is uncertain or concerned about a lesion, cosmetic treatment will not proceed, and you may be advised to obtain appropriate medical assessment.

Why Choose Lipo 360?

At Lipo 360, CryoPen treatment begins with a consultation and suitability assessment, rather than assuming every skin lesion is suitable for cosmetic treatment.

Your practitioner will explain the procedure, possible skin reactions, potential risks and appropriate aftercare so that you can make an informed decision about whether you wish to proceed.

We provide mobile aesthetic treatments for adults in selected areas of the UK, allowing eligible clients to receive treatment at home where appropriate.

Angiofibroma Treatment FAQs

Are angiofibromas cancerous?

Cutaneous angiofibromas are benign skin growths.

However, other skin lesions can sometimes look similar. An unexplained lesion should therefore be appropriately assessed rather than self-diagnosed as an angiofibroma.

Can Lipo 360 diagnose an angiofibroma?

No. Lipo 360 provides cosmetic treatment for suitable lesions that have previously been appropriately assessed and identified as benign.

If a lesion is new, changing, unusual or undiagnosed, you may be advised to seek assessment from a GP, dermatologist or another appropriate healthcare professional before cosmetic treatment is considered.

How does CryoPen work?

CryoPen delivers a controlled application of nitrous oxide to a localised treatment area, providing targeted cryotherapy.

The treated area subsequently goes through a healing process.

Your practitioner will explain how the procedure works and what you may experience before treatment.

Does CryoPen treatment hurt?

Individual experiences vary.

Some people may experience a cold, stinging or uncomfortable sensation during treatment, and the area can feel tender afterwards.

Your practitioner will discuss what you may experience before treatment.

Will one CryoPen treatment remove an angiofibroma?

We cannot guarantee a specific cosmetic outcome or that one treatment will be sufficient.

Some lesions may require further treatment after the skin has completely healed.

Your practitioner can reassess the area and discuss whether another treatment may be appropriate.

Is CryoPen suitable for every skin type?

Suitability for cryotherapy should be assessed on an individual basis.

Pigmentation can change after cryotherapy, so your practitioner will consider your skin type, pigmentation, and other relevant factors when assessing suitability.

Are there risks or side effects?

Cryotherapy can cause temporary skin reactions including redness, tenderness, swelling, blistering, crusting and changes in pigmentation.

Other complications may occur, and healing responses vary between individuals.

We will discuss the potential risks relevant to your treatment during your consultation.

What happens if my practitioner is unsure about my lesion?

If your practitioner is unsure about the lesion or has concerns about its appearance, they will not proceed with cosmetic treatment.

You may instead be advised to seek appropriate medical assessment before cosmetic treatment is considered.

Can an angiofibroma grow back?

Recurrence can occur and depends partly on the angiofibroma type and individual circumstances.

Treatment cannot guarantee that a lesion will not return.

Can multiple angiofibromas be treated?

Multiple angiofibromas can sometimes be associated with underlying medical or genetic conditions.

If you have multiple unexplained lesions, we may recommend an appropriate medical assessment before considering cosmetic treatment.

Book Your CryoPen Consultation

If you have an angiofibroma that has previously been appropriately assessed and identified as benign and you would like to discuss cosmetic treatment, book a consultation with Lipo 360.

We will assess your suitability, explain the CryoPen procedure and aftercare, discuss potential risks and answer your questions before considering treatment.

References & Further Reading

NHS — Actinic keratoses (solar keratoses)
Patient information covering symptoms, when to seek medical advice, treatment options and sun protection.

British Association of Dermatologists — Guidelines for the care of patients with actinic keratosis
Clinical guidance covering diagnosis, assessment, risk and management of actinic keratoses.

England Middlesex